salicylates and methacrylamide

salicylates has been researched along with methacrylamide* in 1 studies

Other Studies

1 other study(ies) available for salicylates and methacrylamide

Article	Year
Polymeric drugs with prolonged sustained delivery of specific anti-aggregant agents for platelets: kinetic analysis of the release mechanism. Journal of biomaterials science. Polymer edition, 2004, Volume: 15, Issue:7 The in vitro aqueous behaviour of a metacryloyloxyethyl [2-(acetyloxy)-4-(trifluoromethyl)]benzoate (THEMA)/N,N'-dimethylacrylamide (DMA) copolymer with a THEMA molar content of 39% (labeled THDMA39) has been investigated. This composition has been selected to achieve a system able to keep both the non-water solubility during the release and the resorbability (and the water solubility) after the completion of the drug release. This copolymer exhibited, at pH 7.4, a constant release during several months, very interesting for a long term treatments required for the application of some cardiovascular devices. A kinetic model has been developed to explain the pseudo-zero-order kinetics of the release process. This model, which considers (from the aqueous studies) a linear increase with time of the amount of water present in the polymeric matrix, has been able to fit adequately the experimental data. Topics: Acrylamides; Biocompatible Materials; Blood Platelets; Drug Design; Free Radicals; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Magnetic Resonance Spectroscopy; Models, Chemical; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymers; Salicylates; Thrombin; Time Factors; Toluene; Water	2004

Article

Year

Polymeric drugs with prolonged sustained delivery of specific anti-aggregant agents for platelets: kinetic analysis of the release mechanism.

Journal of biomaterials science. Polymer edition, 2004, Volume: 15, Issue:7

The in vitro aqueous behaviour of a metacryloyloxyethyl [2-(acetyloxy)-4-(trifluoromethyl)]benzoate (THEMA)/N,N'-dimethylacrylamide (DMA) copolymer with a THEMA molar content of 39% (labeled THDMA39) has been investigated. This composition has been selected to achieve a system able to keep both the non-water solubility during the release and the resorbability (and the water solubility) after the completion of the drug release. This copolymer exhibited, at pH 7.4, a constant release during several months, very interesting for a long term treatments required for the application of some cardiovascular devices. A kinetic model has been developed to explain the pseudo-zero-order kinetics of the release process. This model, which considers (from the aqueous studies) a linear increase with time of the amount of water present in the polymeric matrix, has been able to fit adequately the experimental data.

Topics: Acrylamides; Biocompatible Materials; Blood Platelets; Drug Design; Free Radicals; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Magnetic Resonance Spectroscopy; Models, Chemical; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymers; Salicylates; Thrombin; Time Factors; Toluene; Water

2004